Furthermore, MPO mRNA hepatic expression was positively correlated with risk factors for NASH progression, such as body mass index (BMI) and the percentage of glycated hemoglobin (Table 1) [61]. Here, MPO is linked to metabolic dysfunction-associated steatohepatitis.